Skip to main content

Aptify ID

229
ONS Guidelines Article

ONS Guidelines™ for Cancer Treatment–Related Skin Toxicity

Loretta A. Williams, Pamela K. Ginex, George ...

ONF 10.1188/20.ONF.539-556
ONS Guidelines Article
Online Exclusive Article

Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Sy...

Jingyi Ding, Magdoleen H. Farah, Tarek Nayfeh...

ONF 10.1188/20.ONF.E149-E160

Skin Toxicities

Background

Skin toxicity resulting from cancer treatment can affect the skin, hair, and nails. These reactions can significantly affect patients’ physical functioning, well-being, and quality of life and can cause cancer treatment delays and limitations. Skin toxicity is associated with various chemotherapy agents, targeted agents, and immunotherapy treatments. Some skin toxicities include epidermal growth factor receptor inhibitor (EGFRi) rash, hand-foot skin reaction (HFSR), hand-foot syndrome (HFS or palmar-plantar erythrodysesthesia (PPE)), and alopecia (hair loss).

Article

Nursing Management of Cutaneous Toxicities From Epidermal Growth ...

Martin Wallner, Sabine Köck-Hódi, Shaina Booz...

CJON 10.1188/16.CJON.529-536
Subscribe to Skin Reactions